Requests and green lights for US Dx CLIA waiver hits all time high
This article was originally published in Clinica
The volume of applications seeking a waiver under the Clinical Laboratory Improvement Amendments for a diagnostic test increased five-fold in the fiscal year 2014, but the total numbers are small, and the change may simply reflect routine year-to-year variation.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.